JP2012513403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012513403A5 JP2012513403A5 JP2011542539A JP2011542539A JP2012513403A5 JP 2012513403 A5 JP2012513403 A5 JP 2012513403A5 JP 2011542539 A JP2011542539 A JP 2011542539A JP 2011542539 A JP2011542539 A JP 2011542539A JP 2012513403 A5 JP2012513403 A5 JP 2012513403A5
- Authority
- JP
- Japan
- Prior art keywords
- desmopressin
- patient
- dispenser
- target
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 claims description 86
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 claims description 86
- 229960004281 desmopressin Drugs 0.000 claims description 86
- 239000000203 mixture Substances 0.000 claims description 46
- 239000007921 spray Substances 0.000 claims description 41
- 239000008280 blood Substances 0.000 claims description 30
- 210000004369 blood Anatomy 0.000 claims description 30
- 206010030302 Oliguria Diseases 0.000 claims description 20
- 230000011224 negative regulation of urine volume Effects 0.000 claims description 20
- 238000007920 subcutaneous administration Methods 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 11
- 239000003961 penetration enhancing agent Substances 0.000 claims description 10
- 230000002686 anti-diuretic effect Effects 0.000 claims description 9
- 230000037396 body weight Effects 0.000 claims description 9
- 230000001939 inductive effect Effects 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 210000004877 mucosa Anatomy 0.000 claims description 8
- 238000012377 drug delivery Methods 0.000 claims description 7
- 206010021036 Hyponatraemia Diseases 0.000 claims description 5
- -1 diamidines Chemical class 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 239000012988 Dithioester Substances 0.000 claims description 4
- 239000012080 ambient air Substances 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 150000001409 amidines Chemical class 0.000 claims description 4
- 150000005690 diesters Chemical class 0.000 claims description 4
- 238000009826 distribution Methods 0.000 claims description 4
- 125000005022 dithioester group Chemical group 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- 150000002596 lactones Chemical class 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 150000007970 thio esters Chemical class 0.000 claims description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 2
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 claims 2
- 210000002850 nasal mucosa Anatomy 0.000 claims 2
- 239000003623 enhancer Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 8
- 238000009472 formulation Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 2
- 150000001470 diamides Chemical class 0.000 description 2
- 150000003556 thioamides Chemical class 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940124538 antidiuretic agent Drugs 0.000 description 1
- 239000003160 antidiuretic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13987108P | 2008-12-22 | 2008-12-22 | |
| US61/139,871 | 2008-12-22 | ||
| PCT/US2009/068962 WO2010075266A2 (en) | 2008-12-22 | 2009-12-21 | Safe desmopressin administration |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015080138A Division JP5959076B2 (ja) | 2008-12-22 | 2015-04-09 | 鼻腔内デスモプレシン投与 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012513403A JP2012513403A (ja) | 2012-06-14 |
| JP2012513403A5 true JP2012513403A5 (cg-RX-API-DMAC7.html) | 2013-02-14 |
| JP5731396B2 JP5731396B2 (ja) | 2015-06-10 |
Family
ID=42168193
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011542539A Active JP5731396B2 (ja) | 2008-12-22 | 2009-12-21 | 鼻腔内デスモプレシン投与 |
| JP2015080138A Active JP5959076B2 (ja) | 2008-12-22 | 2015-04-09 | 鼻腔内デスモプレシン投与 |
| JP2016120760A Active JP6389209B2 (ja) | 2008-12-22 | 2016-06-17 | 鼻腔内デスモプレシン投与 |
| JP2018113951A Pending JP2018184407A (ja) | 2008-12-22 | 2018-06-14 | 鼻腔内デスモプレシン投与 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015080138A Active JP5959076B2 (ja) | 2008-12-22 | 2015-04-09 | 鼻腔内デスモプレシン投与 |
| JP2016120760A Active JP6389209B2 (ja) | 2008-12-22 | 2016-06-17 | 鼻腔内デスモプレシン投与 |
| JP2018113951A Pending JP2018184407A (ja) | 2008-12-22 | 2018-06-14 | 鼻腔内デスモプレシン投与 |
Country Status (19)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009021007A1 (en) | 2007-08-06 | 2009-02-12 | Serenity Pharmaceuticals Corporation | Methods and devices for desmopressin drug delivery |
| SG10201509152VA (en) * | 2008-12-22 | 2015-12-30 | Allergan Inc | Intranasal desmopressin administration |
| CA2765221C (en) * | 2009-06-18 | 2017-10-03 | Allergan, Inc. | Safe desmopressin administration |
| EP3024473A1 (en) | 2013-07-23 | 2016-06-01 | Allergan, Inc. | Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor |
| CN105579057A (zh) * | 2013-07-23 | 2016-05-11 | 阿勒根公司 | 包含与β-3-肾上腺素能受体激动剂组合的去氨加压素的方法和组合物 |
| CA2967390A1 (en) | 2014-11-20 | 2016-05-26 | Allergan, Inc. | Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS171787B1 (cg-RX-API-DMAC7.html) | 1973-11-09 | 1976-11-29 | ||
| US4148787A (en) | 1976-05-24 | 1979-04-10 | Ferring Ab | Antidiuretically effective polypeptide and a process for preparing the same |
| US4771769A (en) | 1982-12-20 | 1988-09-20 | Schering Corporation | Hand held metered spray dispenser |
| US4548922A (en) | 1983-06-06 | 1985-10-22 | Beth Israel Hospital | Drug administration |
| US4746508A (en) | 1983-06-06 | 1988-05-24 | Beth Israel Hospital Assn. | Drug administration |
| US5731303A (en) | 1985-12-04 | 1998-03-24 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery compositions |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5112804A (en) | 1987-04-01 | 1992-05-12 | Temple University Of The Commonwealth System Of Higher Education | Pharmaceutical composition and method of intranasal administration |
| US4944429A (en) | 1987-08-28 | 1990-07-31 | Schering Corporation | Manually-operable spray dispenser with locking mechanism |
| US5154122A (en) | 1989-10-20 | 1992-10-13 | Sol Goldschmidt | Shipping device for suspended piece goods |
| CN1060980A (zh) * | 1990-10-26 | 1992-05-13 | 蔡东林 | 多用电控自控微型喷雾器 |
| US5314694A (en) | 1990-10-29 | 1994-05-24 | Alza Corporation | Transdermal formulations, methods and devices |
| US5122383A (en) | 1991-05-17 | 1992-06-16 | Theratech, Inc. | Sorbitan esters as skin permeation enhancers |
| US5227169A (en) | 1991-05-17 | 1993-07-13 | Theratech, Inc. | Sorbitan esters as skin permeation enhancers |
| US5212199A (en) | 1991-05-17 | 1993-05-18 | Theratech, Inc. | Sorbitan esters as skin permeation enhancers |
| IT1255895B (it) | 1992-10-20 | 1995-11-17 | Laura Chiodini | Composizioni farmaceutiche contenenti una calcitonina |
| DK0708657T3 (da) * | 1993-06-29 | 2001-10-15 | Ferring Bv | Sammensætninger til nasal administration af desmopression |
| WO1996040332A1 (en) * | 1995-06-07 | 1996-12-19 | O'neil, Christine | Patient controlled drug delivery device |
| US5763398A (en) * | 1996-06-20 | 1998-06-09 | Ferring B.V. | Nasal administration of desmopressin |
| DE19723133A1 (de) | 1997-06-03 | 1998-12-10 | Caideil M P Teoranta Tourmakea | Austragvorrichtung für Medien |
| US7335186B2 (en) | 1998-03-13 | 2008-02-26 | Alexander George Brian O'Neil | Patient controlled drug delivery device |
| AU3421600A (en) | 1999-02-14 | 2000-08-29 | Ing. Erich Pfeiffer Gmbh | Dispenser for flowable media |
| DE19938798A1 (de) | 1999-08-16 | 2001-03-01 | Pfeiffer Erich Gmbh & Co Kg | Spender für Flüssigkeiten oder für zähflüssige oder versprühbare Produkte |
| DE19940236A1 (de) | 1999-08-25 | 2001-03-08 | Pfeiffer Erich Gmbh & Co Kg | Spender mit manuell betätigbarer Ausbringeinrichtung |
| DE10110742A1 (de) | 2001-02-28 | 2002-09-05 | Pfeiffer Erich Gmbh & Co Kg | Spender für Medien |
| US7244703B2 (en) | 2001-06-22 | 2007-07-17 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for peptide treatment |
| PL200833B1 (pl) | 2001-09-21 | 2009-02-27 | Pfeiffer Erich Gmbh & Co Kg | Dozownik z pojemnikiem aplikowanego środka oraz pompka do dozownika |
| US20030232078A1 (en) | 2001-12-19 | 2003-12-18 | Dong Liang C. | Formulation & dosage form for the controlled delivery of therapeutic agents |
| GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| ITMI20021684A1 (it) * | 2002-07-29 | 2004-01-29 | Therapicon Srl | Composizione farmaceutica di peptide nasale |
| US7186692B2 (en) * | 2002-12-17 | 2007-03-06 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| WO2005046707A1 (en) * | 2003-11-10 | 2005-05-26 | Fein Seymour H | Pharmaceutical compositions including low dosages of desmopressin |
| JP2007513199A (ja) * | 2003-12-08 | 2007-05-24 | ベントレー ファーマスーティカルス,インコーポレイテッド | インスリン治療のための薬学的組成物及び方法 |
| WO2007022345A2 (en) * | 2005-08-17 | 2007-02-22 | Fleming And Company, Pharmaceuticals | Vitamin b12 nasal spray and method of use |
| CN1785448A (zh) * | 2005-11-11 | 2006-06-14 | 广东工业大学 | 医用防染式药雾吸入喷嘴 |
| EP2035031A4 (en) * | 2006-06-08 | 2010-02-24 | Cpex Pharmaceuticals Inc | INSULIN COMPOSITION |
| SG10201509152VA (en) * | 2008-12-22 | 2015-12-30 | Allergan Inc | Intranasal desmopressin administration |
| CA2765221C (en) | 2009-06-18 | 2017-10-03 | Allergan, Inc. | Safe desmopressin administration |
-
2009
- 2009-12-21 SG SG10201509152VA patent/SG10201509152VA/en unknown
- 2009-12-21 EA EA201791732A patent/EA201791732A1/ru unknown
- 2009-12-21 PT PT09796558T patent/PT2381923T/pt unknown
- 2009-12-21 BR BRPI0923557A patent/BRPI0923557A2/pt not_active Application Discontinuation
- 2009-12-21 KR KR1020177017968A patent/KR20170081711A/ko not_active Ceased
- 2009-12-21 CA CA2747998A patent/CA2747998C/en active Active
- 2009-12-21 US US13/141,590 patent/US20120015880A1/en not_active Abandoned
- 2009-12-21 NZ NZ593613A patent/NZ593613A/xx unknown
- 2009-12-21 JP JP2011542539A patent/JP5731396B2/ja active Active
- 2009-12-21 WO PCT/US2009/068962 patent/WO2010075266A2/en not_active Ceased
- 2009-12-21 PL PL09796558.6T patent/PL2381923T5/pl unknown
- 2009-12-21 EA EA201170873A patent/EA028531B1/ru not_active IP Right Cessation
- 2009-12-21 CN CN201610282630.1A patent/CN105963834A/zh active Pending
- 2009-12-21 EP EP09796558.6A patent/EP2381923B2/en active Active
- 2009-12-21 SG SG2011046117A patent/SG172344A1/en unknown
- 2009-12-21 CN CN2009801560968A patent/CN102355888A/zh active Pending
- 2009-12-21 AU AU2009330203A patent/AU2009330203B2/en not_active Ceased
- 2009-12-21 ES ES09796558T patent/ES2692345T5/es active Active
- 2009-12-21 MX MX2011006765A patent/MX2011006765A/es active IP Right Grant
- 2009-12-21 EP EP18174439.2A patent/EP3437633A1/en active Pending
- 2009-12-21 KR KR1020117017070A patent/KR101755042B1/ko active Active
- 2009-12-21 DK DK09796558.6T patent/DK2381923T4/da active
-
2011
- 2011-06-21 IL IL213699A patent/IL213699A/en active IP Right Grant
- 2011-07-22 ZA ZA2011/05420A patent/ZA201105420B/en unknown
-
2015
- 2015-04-09 JP JP2015080138A patent/JP5959076B2/ja active Active
-
2016
- 2016-06-17 JP JP2016120760A patent/JP6389209B2/ja active Active
-
2018
- 2018-06-14 JP JP2018113951A patent/JP2018184407A/ja active Pending
-
2019
- 2019-06-11 US US16/438,040 patent/US20200078542A1/en not_active Abandoned
-
2021
- 2021-05-26 US US17/330,798 patent/US20220126039A1/en not_active Abandoned
-
2023
- 2023-11-10 US US18/506,719 patent/US20240342407A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250241977A1 (en) | Safe desmopressin administration | |
| JP2012530708A5 (cg-RX-API-DMAC7.html) | ||
| US20240342407A1 (en) | Intranasal desmopressin administration | |
| AU2015261630B2 (en) | Intranasal desmopressin administration | |
| HK40060414A (en) | Safe desmopressin administration | |
| HK40060414B (en) | Safe desmopressin administration | |
| HK1250642B (en) | Safe desmopressin administration | |
| HK1172544B (en) | Safe desmopressin administration | |
| HK1172544A (en) | Safe desmopressin administration |